Overexpression of estrogen receptor beta and its prognostic significance among malignant pleural mesothelioma patients

被引:0
|
作者
Helali, Mariam [1 ,3 ]
Abdelmotal, Ahmed [1 ]
Gobran, Nagy [1 ]
El Ghazaly, Hesham [1 ]
El Mahdy, Manal [2 ]
Karim, Khaled [1 ]
机构
[1] Ain Shams Univ, Fac Med, Clin Oncol Dept, Cairo, Egypt
[2] Ain Shams Univ, Fac Med, Pathol Dept, Cairo, Egypt
[3] 38 Abbassia,Next Al Nour Mosque, Cairo, Egypt
关键词
mesothelioma; ER beta; prognostic; biomarkers; HEALTH;
D O I
10.4103/ecdt.ecdt_25_23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The overexpression of estrogen receptor beta (ER beta) and its correlation with prognosis of malignant mesothelioma remains controversial and unexplored. This study aimed at studying ER beta expression in tumour tissue in patients with pleural mesothelioma and its association with clinical and pathological factors and survival analysis. Material and methods A prospective cohort study was conducted on patients who were diagnosed with malignant pleural mesothelioma (MPM) in Ain Shams university hospitals, the primary end point was to correlate ER beta overexpression that was analysed by immunohistochemistry (IHC) on paraffin tissue blocks with 1-year overall survival (OS) among MPM patients, the secondary endpoint was to correlate ER beta overexpression with 1-year progression free survival (PFS) and response to platinum-based chemotherapy among MPM patients. Results A total 42 MPM patients were included, High ER beta expression (modified Allred score 7-9) was reported in 9.5% of the patients (4 cases), moderate expression (modified Allred score 4-6) was reported in 28.6% of the patients(12 cases), weak and negative expression ( modified Allred score 0-3) was reported in 61% of the patients(26 cases), percent of ER beta positive cases was 69% of the total patients, there was no statistical difference as regard age (p value:0.8), sex(p value:0.4), stage (p value: 0.71), ECOG (p value :0.84) , histological subtype(p value:0.17) and response to platinum based treatment (p value:0.5) across the 3 groups of patients (high, moderate , weak and negative ER beta on tumour tissues) there was no statistically significant difference in OS and PFS for ER beta overexpression. Conclusion The overexpression of ER beta was not associated with improved OS or PFS in mesothelioma patients, despite high rate of ER beta positive cases in our analysis, larger sample size would be recommended for more solid conclusions
引用
收藏
页码:85 / 90
页数:6
相关论文
共 50 条
  • [1] Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma
    Rafael Rodriguez-Cid, Jeronimo
    Garcia-Acevedo, Orlando
    Benjamin-Contreras, Javier
    Bonilla-Molina, Diana
    Rafael Flores-Marinelarena, Rodrigo
    Martinez-Barrera, Luis
    Arturo Alatorre-Alexander, Jorge
    Paola Sanchez-Rios, Carla
    del Rosario Flores-Soto, Maria
    Javier Santillan-Doherty, Patricio
    Sagrario Pena-Mirabal, Erika
    JOURNAL OF THORACIC DISEASE, 2019, 11 (04) : 1456 - 1464
  • [2] Expression of Estrogen Receptor Beta (ERb) and its Prognostic Value in the Pleural Mesothelioma.
    Rodriguez-Cid, J.
    Garcia Acevedo, O.
    Bonilla-Molina, D.
    Alatorre Alexander, J. A.
    Martinez Barrera, L.
    Benjamin Contreras, J.
    Pena Mirabal, E. S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S754 - S754
  • [3] Epidermal Growth Factor Receptor Overexpression in Malignant Pleural Mesothelioma: Prognostic Correlations
    Rena, Ottavio
    Boldorini, Luciano R.
    Gaudino, Erica
    Casadio, Caterina
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (06) : 701 - 705
  • [4] Variation in Merlin expression and its prognostic significance in malignant pleural mesothelioma
    Dhakal, Ajay
    Pokharel, Saraswati
    Wang, Katy
    Demmy, Todd
    Nwogu, Chukwumere E.
    Yendamuri, Sai S.
    Dy, Grace
    CANCER RESEARCH, 2017, 77
  • [5] Estrogen Receptor Beta (ERβ) Expression in Different Subtypes of Malignant Pleural Mesothelioma
    Pourdowlat, Guitti
    Parvizi, Maryam
    Boyadjian, Shogher
    Shamaei, Masoud
    Pourabdollah, Mihan
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2022, 18 (01) : 50 - 56
  • [6] Prognostic significance of osteopontin expression in malignant pleural mesothelioma
    Cappia, Susanna
    Righi, Luisella
    Ceppi, Paolo
    Volante, Marco
    Bacillo, Elisa
    Ardissone, Francesco
    Mirabelli, Dario
    Scagliotti, Giorgio V.
    Papotti, Mauro
    VIRCHOWS ARCHIV, 2007, 451 (02) : 431 - 431
  • [7] Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM)
    Pinelli, Valentina
    Sivori, Massimiliano
    Canessa, Pier Aldo
    Fontana, Vincenzo
    Pistillo, Maria Pia
    Ferro, Paola
    Franceschini, Maria Cristina
    Vigani, Antonella
    Roncella, Silvio
    Battolla, Enrico
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [8] Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma
    Yamagishi, Tomoko
    Fujimoto, Nobukazu
    Nishi, Hideyuki
    Miyamoto, Yosuke
    Hara, Naofumi
    Asano, Michiko
    Fuchimoto, Yasuko
    Wada, Sae
    Kitamura, Kenichi
    Ozaki, Shinji
    Kishimoto, Takumi
    LUNG CANCER, 2015, 90 (01) : 111 - 117
  • [9] Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma
    Emri, S
    Akbulut, H
    Zorlu, F
    Dinçol, D
    Akay, H
    Güngen, Y
    Içli, F
    LUNG CANCER, 2001, 33 (2-3) : 109 - 114
  • [10] Prognostic Factors in Patients with Malignant Pleural Mesothelioma
    Kurchenkov, Aleksey N.
    Kurchin, Vyacheslav P.
    Zharkov, Vladimir V.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2015, 5 (01) : 7 - 10